摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-cyclopentyl-2-(4-hydroxy-2-oxo-1,2-dihydroquinolin-3-yl)acetamide

中文名称
——
中文别名
——
英文名称
N-cyclopentyl-2-(4-hydroxy-2-oxo-1,2-dihydroquinolin-3-yl)acetamide
英文别名
N-cyclopentyl-2-(4-hydroxy-2-oxo-1H-quinolin-3-yl)acetamide
N-cyclopentyl-2-(4-hydroxy-2-oxo-1,2-dihydroquinolin-3-yl)acetamide化学式
CAS
——
化学式
C16H18N2O3
mdl
——
分子量
286.33
InChiKey
SXMMZIYVHISMOM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    21
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    78.4
  • 氢给体数:
    3
  • 氢受体数:
    4

文献信息

  • COMBINATIONAL COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER
    申请人:ArQule, Inc.
    公开号:US20150328208A1
    公开(公告)日:2015-11-19
    The present invention provides methods of treating a cell proliferative disorder, such as a cancer, by administering to a subject in need thereof a therapeutically effective amount of a pyrroloquinolinyl-pyrrole-2,5-dione compound or a pyrroloquinolinyl-pyrrolidine-2,5-dione compound in combination with a therapeutically effective amount of a second anti-proliferative agent.
    本发明提供了治疗细胞增殖紊乱(如癌症)的方法,通过向需要的受试者投予一种吡啶喹啉吡咯-2,5-二酮化合物或吡啶喹啉吡咯啉-2,5-二酮化合物的治疗有效量,与第二种抗增殖剂的治疗有效量结合使用。
  • [EN] COMBINATIONAL COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER<br/>[FR] COMPOSITIONS COMBINATOIRES ET PROCÉDÉS POUR LE TRAITEMENT DU CANCER
    申请人:ARQULE INC
    公开号:WO2010093789A2
    公开(公告)日:2010-08-19
    The present invention provides methods of treating a cell proliferative disorder, such as a cancer, by administering to a subject in need thereof a therapeutically effective amount of a pyrroloquinolinyl-pyrrole-2,5-dione compound or a pyrroloquinolinyl-pyrrolidine-2,5-dione compound in combination with a therapeutically effective amount of a second anti-proliferative agent.
    本发明提供了一种治疗细胞增殖性疾病(如癌症)的方法,通过向需要治疗的受试者施用一种吡咯喹啉基-吡咯烷-2,5-二酮化合物或吡咯喹啉基-吡咯啉-2,5-二酮化合物的治疗有效量,与治疗有效量的第二种抗增殖剂联合使用。
  • Compositions and methods for treatment of cancer
    申请人:Li J. Chiang
    公开号:US20060223760A1
    公开(公告)日:2006-10-05
    The present invention relates to pyrroloquinolinyl-pyrrole-2,5-dione compounds and pyrroloquinolinyl-pyrrolidine-2,5-dione compounds, and methods of preparation of these compounds. The present invention also relates to pharmaceutical compositions comprising pyrroloquinolinyl-pyrrole-2,5-dione compounds and pyrroloquinolinyl-pyrrolidine-2,5-dione compounds. The present invention provides methods of treating a cell proliferative disorder, such as a cancer, by administering to a subject in need thereof a therapeutically effective amount of a pyrroloquinolinyl-pyrrole-2,5-dione compound or pyrroloquinolinyl-pyrrolidine-2,5-dione compound of the present invention.
    本发明涉及吡咯喹啉吡咯-2,5-二酮化合物和吡咯喹啉吡咯啉-2,5-二酮化合物,以及这些化合物的制备方法。本发明还涉及包含吡咯喹啉吡咯-2,5-二酮化合物和吡咯喹啉吡咯啉-2,5-二酮化合物的药物组合物。本发明提供了通过向需要治疗细胞增殖性疾病,如癌症的患者投与本发明的吡咯喹啉吡咯-2,5-二酮化合物或吡咯喹啉吡咯啉-2,5-二酮化合物的治疗有效量的方法。
  • Compositions and Methods for the Treatment of Cancer
    申请人:Westlund Neil
    公开号:US20100183603A1
    公开(公告)日:2010-07-22
    The present invention relates to pyrrolidine-2,5-dione compounds, and methods of preparation of these compounds. The present invention also relates to pharmaceutical compositions comprising pyrrolidine-2,5-dione compounds. The present invention provides methods of treating a cell proliferative disorder, such as a cancer, by administering to a subject in need thereof a therapeutically effective amount of a compound or pyrrolidine-2,5-dione compound of the present invention. (Ia) (Ib) (IIa) (IIIb) Where U is independently selected from: (I) or (II) where U is independently selected from:
    本发明涉及吡咯烷-2,5-二酮化合物及其制备方法。本发明还涉及包含吡咯烷-2,5-二酮化合物的制药组合物。本发明提供了通过向需要治疗细胞增殖性疾病,如癌症的患者施用本发明化合物或吡咯烷-2,5-二酮化合物的治疗有效剂量来治疗该疾病的方法。(Ia) (Ib) (IIa) (IIIb)其中U独立地选自:(I)或(II),其中U独立地选自:
  • Compositions and Methods for Treatment of Cancer
    申请人:Li Chiang J.
    公开号:US20100221251A1
    公开(公告)日:2010-09-02
    The present invention relates to pyrroloquinolinyl-pyrrole-2,5-dione compounds and pyrroloquinolinyl-pyrrolidine-2,5-dione compounds, and methods of preparation of these compounds. The present invention also relates to pharmaceutical compositions comprising pyrroloquinolinyl-pyrrole-2,5-dione compounds and pyrroloquinolinyl-pyrrolidine-2,5-dione compounds. The present invention provides methods of treating a cell proliferative disorder, such as a cancer, by administering to a subject in need thereof a therapeutically effective amount of a pyrroloquinolinyl-pyrrole-2,5-dione compound or pyrroloquinolinyl-pyrrolidine-2,5-dione compound of the present invention.
    本发明涉及吡咯喹啉吡咯-2,5-二酮化合物和吡咯喹啉吡咯烷-2,5-二酮化合物及其制备方法。本发明还涉及包含吡咯喹啉吡咯-2,5-二酮化合物和吡咯喹啉吡咯烷-2,5-二酮化合物的制药组合物。本发明提供了通过向需要治疗细胞增殖性疾病,例如癌症的患者施用本发明的吡咯喹啉吡咯-2,5-二酮化合物或吡咯喹啉吡咯烷-2,5-二酮化合物的治疗有效量的方法。
查看更多